Dr. Manuel Colucci, a researcher at the Molecular Oncology Lab of the Institute of Oncology Research (IOR), directed by Prof. Andrea Alimonti and member of SenoTarg, has been awarded the “Best Oral Presentation” at the “13th Research and Innovation Day in Human Medicine of Southern Switzerland,” held in Lugano on September 27, 2024. Dr.…
Scientists at the Institute of Oncology Research (IOR), the Veneto Institute of Molecular Medicine (VIMM), and the University of Padua, in collaboration with SenoTarg members, have discovered a new natural therapeutic that combats aging, published in Nature Aging. Aging is a major risk factor for chronic diseases like Alzheimer’s, arthritis, cancer, and chronic kidney disease.…
We are pleased to announce that Anna Rinaldi, Postdoctoral Researcher at the Nephrology Laboratory, has been awarded the prize for her poster titled “Identification of a Naturally Derived Senolytic Compound to Prevent Kidney Aging” This research is a key component of the SINERGIA SENOTARG project, which aims to advance our understanding and treatment of…
Laboratory of Integrative Systems Physiology (LISP, Auwerx lab), as part of the SenoTarg consortium committed to advancing research in aging and mitochondrial stress, has released two innovative scientific articles that shed light on new aspects of the effect of mitochondrial stress. These works represent significant progress in understanding the mechanisms behind metabolic disorders and…
In September 2023, Rendon Angel was awarded the Best Presentation Award at the Translational Research during the 12th Giornata della Ricerca at USI Università della Svizzera italiana. This recognition highlighted her innovative contributions to the SenoTARG project. Her success continued in November 2023, when she received the Best Poster Award from the Italian Society for Cardiovascular…
Anna Rinaldi, Postdoctoral Researcher at the Nephrology Laboratory guided by Professor Cippà, won the ERA prize for the presentation entitled “Identification of a novel senolytic compound to prevent chronic kidney injury and fibrosis”.
Laborathory for Cariovascular Theranostics, as part of the SenoTarg consortium committed to advancing research in aging and cardiovascular health, has released two innovative scientific articles that shed light on new aspects of cardiomyocyte. These works represent significant progress in understanding the mechanisms behind heart aging and stress-induced senescence, key areas of focus for the consortium.…
Exciting time together, many results achieved, stunning discussion and much more to come!
The Molecular Oncology research group, led by Prof. Andrea Alimonti at the Institute of Oncology Research (IOR, affiliated with USI and part of Bios+), a member of the SenoTarg consortium, has uncovered a novel method using bioinformatics and artificial intelligence to selectively target and eliminate specific cells involved in metastasis. The Problem Metastasis, the spread…
The first SenoTarg meeting in presence, what an amazing and inspiring meeting at EPFL in Lausanne!We are ready to drive the change and contribute to the filed of senescence!
